Fat loss
What was measured, over what duration, and in which study population?
METABOLIC PEPTIDE RESEARCH
Better evidence.
Better research
questions.
We’re developing software that brings metabolic peptide studies into a clearer, more traceable research workflow.
Working software prototypeActive development
THE RESEARCH LANDSCAPE04 PATHWAYS
DESIGNED FOR
Academic researchersBiotechnology teamsEvidence review workflows01 — RESEARCH FOCUS
Weight change is only
part of the question.
PT Peptide’s initial focus is the quality of weight loss: how studies describe fat loss, lean tissue, muscle function and safety. These are distinct outcomes that deserve a consistent frame of comparison.
Lean tissue
Which body-composition method was used, and what can it actually tell us?
Muscle function
Were strength or mobility measured alongside changes in body composition?
Safety & context
What adverse events, limitations and uncertainties were reported?
A MULTI-PATHWAY RESEARCH SCOPE
Explore the focus areas
SINGLE-PATHWAY STUDIES
A starting point for structured comparison.
GLP-1 receptor agonist studies, including semaglutide research, provide a foundation for examining study populations, comparators and reported outcomes.
Read an example study02 — THE PLANNED WORKFLOW
From scattered findings
to questions worth testing.
The product is being developed around a simple principle: every research claim should remain connected to its source and its context.
See the development planCollect the relevant evidence
Start with published studies and trial information selected for the research question.
Give findings a consistent structure
Capture study population, design, duration, comparators, outcome definitions and safety findings.
Compare with context intact
Surface differences, missing measures and conflicting findings without treating unlike studies as interchangeable.
Support the next research question
Prepare source-linked comparisons and testable hypotheses for researchers to review and prioritize.
03 — DEVELOPMENT STATUS
A working foundation.
A focused next phase.
PT Peptide has a working software prototype and is under active development. The next phase focuses on source-linked evidence comparison and a carefully evaluated research workflow.
CURRENT STAGE
Working software
prototype
The prototype is maintained in a separate development environment. This domain is the public project and information website; it does not host the research application.
Prototype existsActive development
PLANNED PRODUCT WORK
Structured evidence comparison
Planned capabilities include structured extraction, source-linked summaries and identification of conflicting findings for researcher review.
NEXT VALIDATION STEP
A manually checked benchmark
Evaluate extraction accuracy, citation validity and unsupported claims against a curated set of reviewed publications.
PLANNED PILOT
Researcher feedback and practical value
Assess review time, usability and cost per study before broadening the product’s scope.
04 — SCIENTIFIC CONTEXT
Start with
the original studies.
Selected published research illustrates the field PT Peptide is being built to help researchers explore. These are external studies, not research conducted by PT Peptide.
BODY COMPOSITION
AMYLIN + GLP-1
MULTI-RECEPTOR RESEARCH
Body composition changes during weight reduction with tirzepatide
SURMOUNT-1 substudy · Diabetes, Obesity and Metabolism · 2025
Coadministered cagrilintide and semaglutide in adults with overweight or obesity
REDEFINE 1 · The New England Journal of Medicine · 2025
Triple-hormone-receptor agonist retatrutide for obesity
Phase 2 trial · The New England Journal of Medicine · 2023
05 — ABOUT THE PROJECT
Independent development.
Research in focus.
PT Peptide is a founder-led research software project based in Lisbon, Portugal. Our aim is to make metabolic peptide evidence easier to inspect, compare and turn into well-framed research questions.
The project is led by Zafer Genç. Development is focused on a practical software workflow for academic and biotechnology teams.
LET’S CONNECT
Working on a question
in peptide research?
Get in touch about the project, research workflows or potential future collaboration.